Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Antonini

Showing results (61-70 of 495) with videos related to

Pageof 50
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Medical and surgical management of advanced Parkinson's diseaseAngelo Antonini, Elena Moro, Clecio Godeiro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson's diseaseAngelo Antonini, Luisa Mirò, Carlo Castiglioni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2024
Reply to: "Rethinking Parkinson's Disease: A Syndromic Perspective"Tiago F Outeiro, Angelo Antonini, Joaquim J Ferreira
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 16, 2018
Disease progression in Parkinson subtypes: the PPMI datasetDarko Aleksovski, Dragana Miljkovic, Daniele Bravi, et al.
Expert Opinion on Investigational Drugs|May 19, 2020
Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trialsAngelo Antonini, Daniele Bravi, Michele Sandre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2017
Cognitive impairment in multiple system atrophyEleonora Fiorenzato, Angelo Antonini, Gregor Wenning, et al.
Postgraduate Medicine|August 20, 2019
Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's diseaseStefania Pezzoli, Annachiara Cagnin, Angelo Antonini, et al.
Current Neuropharmacology|February 4, 2021
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's DiseaseAnna Masato, Michele Sandre, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 10, 2022
Early Compensatory Mechanisms in LRRK2 Mutation CarriersGiovanni Palermo, Daniela Frosini, Angelo Antonini, et al.
Expert Opinion on Drug Delivery|October 17, 2025
Infusion therapies for Parkinson's disease: where are we in 2025?Leonardo Rigon, Carmelo Fogliano, Per Odin, et al.
Pageof 50

Showing results (61-70 of 495) with videos related to

Sort By:
Pageof 50
Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2018
Medical and surgical management of advanced Parkinson's diseaseAngelo Antonini, Elena Moro, Clecio Godeiro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 22, 2009
The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson's diseaseAngelo Antonini, Luisa Mirò, Carlo Castiglioni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 26, 2024
Reply to: "Rethinking Parkinson's Disease: A Syndromic Perspective"Tiago F Outeiro, Angelo Antonini, Joaquim J Ferreira
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 16, 2018
Disease progression in Parkinson subtypes: the PPMI datasetDarko Aleksovski, Dragana Miljkovic, Daniele Bravi, et al.
Expert Opinion on Investigational Drugs|May 19, 2020
Immunization therapies for Parkinson's disease: state of the art and considerations for future clinical trialsAngelo Antonini, Daniele Bravi, Michele Sandre, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 4, 2017
Cognitive impairment in multiple system atrophyEleonora Fiorenzato, Angelo Antonini, Gregor Wenning, et al.
Postgraduate Medicine|August 20, 2019
Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's diseaseStefania Pezzoli, Annachiara Cagnin, Angelo Antonini, et al.
Current Neuropharmacology|February 4, 2021
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's DiseaseAnna Masato, Michele Sandre, Angelo Antonini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 10, 2022
Early Compensatory Mechanisms in LRRK2 Mutation CarriersGiovanni Palermo, Daniela Frosini, Angelo Antonini, et al.
Expert Opinion on Drug Delivery|October 17, 2025
Infusion therapies for Parkinson's disease: where are we in 2025?Leonardo Rigon, Carmelo Fogliano, Per Odin, et al.
Pageof 50